Efficacy and Safety of Inebilizumab Among Non-White Demographic Groups with Neuromyelitis Optica Spectrum Disorder: N-MOmentum Study Subgroup Analysis (P11-8.007)
To evaluate the efficacy and safety of inebilizumab(INEB) in AQP4+ NMOSD participants who self-identified as Asian, Hispanic/Latino(H/L), and Black/African American(B/AA) in the N-MOmentum study.
Authors
- Bruce Cree (ORCID: https://orcid.org/0000-0001-7689-2533)
- Friedemann Paul (ORCID: https://orcid.org/0000-0002-6378-0070)
- Kristina R. Patterson (ORCID: https://orcid.org/0000-0002-6421-6869)
- Yanping Wu (ORCID: https://orcid.org/0000-0003-1273-4258)
- Daniel Cimbora (ORCID: https://orcid.org/0000-0001-9835-1527)
- Kazuo Fujihara
Institutions
- Texas Tech University (US)
- Amgen (United States) (US)
- University of California, San Francisco (US)
- Tohoku University (JP)
- Charité - Universitätsmedizin Berlin (DE)
- Texas Tech University Health Sciences Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210761
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00